|
2025-04-15 |
2025-03-31 |
V
Vente
|
McHutchison John G
Administrateur non-exécutif
|
757
-4.0%
9,85
7 455 USD
|
757
-4.0%
|
9,85
|
7 455 USD
|
|
|
2025-04-01 |
2025-03-31 |
VP
Vente planifiée
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
355
-2.3%
9,85
3 496 USD
|
355
-2.3%
|
9,85
|
3 496 USD
|
|
|
2025-04-01 |
2025-03-31 |
V
Vente
|
Bjorkquist Jeanette M
Principal Accounting Officer
Dirigeant
|
180
-3.8%
9,85
1 773 USD
|
180
-3.8%
|
9,85
|
1 773 USD
|
|
|
2025-04-01 |
2025-03-31 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
197
-1.7%
9,85
1 940 USD
|
197
-1.7%
|
9,85
|
1 940 USD
|
|
|
2024-12-31 |
2024-12-30 |
A
Achat
|
Houghton Michael
Administrateur non-exécutif
|
3 202
+inf%
15,61
49 998 USD
|
3 202
+inf%
|
15,61
|
49 998 USD
|
|
|
2024-12-23 |
2024-12-19 |
A
Achat
|
GILEAD SCIENCES, INC.
Actionnaire important
|
940 499
+74.1%
21,37
20 098 464 USD
|
940 499
+74.1%
|
21,37
|
20 098 464 USD
|
|
|
2024-11-26 |
2024-11-25 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
5 000
+0.7%
14,85
74 250 USD
|
5 000
+0.7%
|
14,85
|
74 250 USD
|
|
|
2024-11-26 |
2024-11-25 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
2 976
+0.4%
15,00
44 640 USD
|
2 976
+0.4%
|
15,00
|
44 640 USD
|
|
|
2024-11-26 |
2024-11-22 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
17 024
+2.4%
14,87
253 104 USD
|
17 024
+2.4%
|
14,87
|
253 104 USD
|
|
|
2024-11-19 |
2024-11-18 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
40
-0.3%
16,29
652 USD
|
40
-0.3%
|
16,29
|
652 USD
|
|
|
2024-10-09 |
2024-10-08 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
10 000
+1.4%
14,58
145 800 USD
|
10 000
+1.4%
|
14,58
|
145 800 USD
|
|
|
2024-10-04 |
2024-10-03 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
197
-1.3%
14,81
2 918 USD
|
197
-1.3%
|
14,81
|
2 918 USD
|
|
|
2024-10-04 |
2024-10-03 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
157
-1.3%
14,81
2 325 USD
|
157
-1.3%
|
14,81
|
2 325 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
785
-6.1%
14,23
11 173 USD
|
785
-6.1%
|
14,23
|
11 173 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
981
-6.1%
14,23
13 962 USD
|
981
-6.1%
|
14,23
|
13 962 USD
|
|
|
2024-07-08 |
2024-07-05 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
4 438
+0.6%
12,52
55 564 USD
|
4 438
+0.6%
|
12,52
|
55 564 USD
|
|
|
2024-07-08 |
2024-07-03 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
4 562
+0.7%
12,29
56 067 USD
|
4 562
+0.7%
|
12,29
|
56 067 USD
|
|
|
2024-05-24 |
2024-05-23 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
172
-1.3%
14,93
2 569 USD
|
172
-1.3%
|
14,93
|
2 569 USD
|
|
|
2024-05-24 |
2024-05-23 |
VP
Vente planifiée
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
549
-3.3%
14,93
8 199 USD
|
549
-3.3%
|
14,93
|
8 199 USD
|
|
|
2024-05-24 |
2024-05-23 |
V
Vente
|
Bjorkquist Jeanette M
Principal Accounting Officer
Dirigeant
|
24
-0.8%
14,93
358 USD
|
24
-0.8%
|
14,93
|
358 USD
|
|
|
2024-05-24 |
2024-05-23 |
V
Vente
|
McHutchison John G
Administrateur non-exécutif
|
2 117
-10.0%
14,93
31 615 USD
|
2 117
-10.0%
|
14,93
|
31 615 USD
|
|
|
2024-05-01 |
2024-04-30 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
1 569
-8.7%
12,71
19 937 USD
|
1 569
-8.7%
|
12,71
|
19 937 USD
|
|
|
2024-05-01 |
2024-04-30 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
1 255
-8.8%
12,71
15 947 USD
|
1 255
-8.8%
|
12,71
|
15 947 USD
|
|
|
2024-04-02 |
2024-04-01 |
V
Vente
|
Bjorkquist Jeanette M
Principal Accounting Officer
Dirigeant
|
114
-3.5%
13,07
1 490 USD
|
114
-3.5%
|
13,07
|
1 490 USD
|
|
|
2024-04-02 |
2024-04-01 |
V
Vente
|
McHutchison John G
Administrateur non-exécutif
|
1 206
-5.4%
13,07
15 765 USD
|
1 206
-5.4%
|
13,07
|
15 765 USD
|
|
|
2024-04-02 |
2024-04-01 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
197
-1.8%
13,07
2 575 USD
|
197
-1.8%
|
13,07
|
2 575 USD
|
|
|
2024-04-02 |
2024-04-01 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
354
-2.5%
13,07
4 627 USD
|
354
-2.5%
|
13,07
|
4 627 USD
|
|
|
2024-03-29 |
2024-03-27 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
392
-2.7%
12,87
5 045 USD
|
392
-2.7%
|
12,87
|
5 045 USD
|
|
|
2024-01-19 |
2024-01-18 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
345 086
+4.4%
0,80
276 069 USD
|
345 086
+4.4%
|
0,80
|
276 069 USD
|
|
|
2024-01-19 |
2024-01-17 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
299 994
+4.0%
0,78
235 195 USD
|
299 994
+4.0%
|
0,78
|
235 195 USD
|
|
|
2023-11-22 |
2023-11-21 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
100 000
+1.3%
0,67
66 700 USD
|
100 000
+1.3%
|
0,67
|
66 700 USD
|
|
|
2023-11-22 |
2023-11-20 |
A
Achat
|
Schornstein Alexander
Actionnaire important
|
300 000
+4.2%
0,72
215 400 USD
|
300 000
+4.2%
|
0,72
|
215 400 USD
|
|
|
2023-11-21 |
2023-11-17 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
477
-0.5%
0,69
329 USD
|
477
-0.5%
|
0,69
|
329 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
2 363
-1.3%
0,80
1 879 USD
|
2 363
-1.3%
|
0,80
|
1 879 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Vente
|
Delaney William E IV
Chief Scientific Officer
Dirigeant
|
1 891
-1.2%
0,80
1 504 USD
|
1 891
-1.2%
|
0,80
|
1 504 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Vente
|
White Nicole S
Chief Manufacturing Officer
Dirigeant
|
1 891
-2.0%
0,80
1 504 USD
|
1 891
-2.0%
|
0,80
|
1 504 USD
|
|
|
2023-08-03 |
2023-08-02 |
V
Vente
|
Delaney William E IV
Chief Scientific Officer
Dirigeant
|
9 461
-6.2%
1,09
10 293 USD
|
9 461
-6.2%
|
1,09
|
10 293 USD
|
|
|
2023-08-03 |
2023-08-02 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
11 827
-6.7%
1,09
12 867 USD
|
11 827
-6.7%
|
1,09
|
12 867 USD
|
|
|
2023-07-25 |
2023-07-24 |
V
Vente
|
Bjorkquist Jeanette M
Principal Accounting Officer
Dirigeant
|
844
-3.1%
1,07
900 USD
|
844
-3.1%
|
1,07
|
900 USD
|
|
|
2023-05-31 |
2023-05-30 |
V
Vente
|
Delaney William E IV
Chief Scientific Officer
Dirigeant
|
4 232
-3.6%
0,96
4 046 USD
|
4 232
-3.6%
|
0,96
|
4 046 USD
|
|
|
2023-05-24 |
2023-05-23 |
V
Vente
|
Bjorkquist Jeanette M
Principal Accounting Officer
Dirigeant
|
274
-1.0%
1,04
285 USD
|
274
-1.0%
|
1,04
|
285 USD
|
|
|
2023-05-24 |
2023-05-23 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
6 561
-4.9%
1,04
6 825 USD
|
6 561
-4.9%
|
1,04
|
6 825 USD
|
|
|
2023-05-24 |
2023-05-23 |
V
Vente
|
Delaney William E IV
Chief Scientific Officer
Dirigeant
|
6 561
-5.3%
1,04
6 825 USD
|
6 561
-5.3%
|
1,04
|
6 825 USD
|
|
|
2023-05-24 |
2023-05-23 |
V
Vente
|
McHutchison John G
Administrateur non-exécutif
|
25 972
-13.3%
1,04
27 019 USD
|
25 972
-13.3%
|
1,04
|
27 019 USD
|
|
|
2023-03-28 |
2023-03-27 |
V
Vente
|
Okazaki Jason A
CEO and President
Administrateur exécutif
|
4 693
-4.4%
1,02
4 785 USD
|
4 693
-4.4%
|
1,02
|
4 785 USD
|
|
|
2022-08-10 |
2022-08-08 |
VP
Vente planifiée
|
McHutchison John G
Chief Executive Officer
Administrateur exécutif
|
12 314
-6.0%
2,13
26 200 USD
|
12 314
-6.0%
|
2,13
|
26 200 USD
|
|
|
2022-07-26 |
2022-07-25 |
VP
Vente planifiée
|
Samar Michael P.
Chief Financial Officer
Dirigeant
|
2 020
-2.5%
2,22
4 479 USD
|
2 020
-2.5%
|
2,22
|
4 479 USD
|
|
|
2022-06-02 |
2022-05-31 |
VP
Vente planifiée
|
Delaney William E IV
Chief Scientific Officer
Dirigeant
|
4 164
-5.2%
1,92
8 005 USD
|
4 164
-5.2%
|
1,92
|
8 005 USD
|
|
|
2022-03-29 |
2022-03-28 |
VP
Vente planifiée
|
Okazaki Jason A
Chief Operating Officer
Dirigeant
|
4 617
-6.7%
2,24
10 363 USD
|
4 617
-6.7%
|
2,24
|
10 363 USD
|
|
|
2021-06-01 |
2021-05-27 |
VP
Vente planifiée
|
Delaney William E IV
Chief Scientific Officer
Dirigeant
|
4 129
-7.2%
4,03
16 637 USD
|
4 129
-7.2%
|
4,03
|
16 637 USD
|
|
|
2020-12-15 |
2020-12-14 |
VP
Vente planifiée
|
Papkoff Jacqueline Sybil
SVP-CSO Microbiome
Dirigeant
|
1 297
-3.4%
6,15
7 983 USD
|
1 297
-3.4%
|
6,15
|
7 983 USD
|
|
|
2020-11-10 |
2020-11-09 |
VP
Vente planifiée
|
Stamm Luisa M
Chief Medical Officer
Dirigeant
|
4 397
-36.6%
5,10
22 404 USD
|
4 397
-36.6%
|
5,10
|
22 404 USD
|
|
|
2020-08-10 |
2020-08-07 |
VP
Vente planifiée
|
McHutchison John G
CEO and President
Administrateur exécutif
|
756
-0.5%
22,50
17 010 USD
|
756
-0.5%
|
22,50
|
17 010 USD
|
|
|
2020-08-10 |
2020-08-07 |
VP
Vente planifiée
|
McHutchison John G
CEO and President
Administrateur exécutif
|
11 395
-7.6%
21,76
247 907 USD
|
11 395
-7.6%
|
21,76
|
247 907 USD
|
|
|
2020-03-31 |
2020-03-31 |
VP
Vente planifiée
|
Colonno Richard James
EVP & CSO, Virology Ops
Dirigeant
|
7 812
-5.4%
15,04
117 524 USD
|
7 812
-5.4%
|
15,04
|
117 524 USD
|
|
|
2020-03-31 |
2020-03-30 |
VP
Vente planifiée
|
Papkoff Jacqueline Sybil
SVP-CSO Microbiome
Dirigeant
|
1 254
-3.1%
14,22
17 831 USD
|
1 254
-3.1%
|
14,22
|
17 831 USD
|
|
|
2019-12-16 |
2019-12-13 |
VP
Vente planifiée
|
Papkoff Jacqueline Sybil
SVP-CSO Microbiome
Dirigeant
|
1 460
-6.0%
21,00
30 662 USD
|
1 460
-6.0%
|
21,00
|
30 662 USD
|
|
|
2019-12-16 |
2019-12-12 |
VP
Vente planifiée
|
Colonno Richard James
EVP & CSO, Virology Ops
Dirigeant
|
33 061
-20.5%
25,00
826 578 USD
|
33 061
-20.5%
|
25,00
|
826 578 USD
|
|
|
2018-09-07 |
2018-09-06 |
VP
Vente planifiée
|
Lopatin Uri A
Chief Med. Off., VP Res. Dev.
Dirigeant
|
336
-0.1%
40,01
13 442 USD
|
336
-0.1%
|
40,01
|
13 442 USD
|
|
|
2018-09-07 |
2018-09-05 |
VP
Vente planifiée
|
Lopatin Uri A
Chief Med. Off., VP Res. Dev.
Dirigeant
|
15 204
-2.4%
40,09
609 547 USD
|
15 204
-2.4%
|
40,09
|
609 547 USD
|
|
|
2018-07-20 |
2018-07-19 |
A
Achat
|
Small Derek A
CEO and President
Administrateur exécutif
|
1 200
+0.2%
41,77
50 123 USD
|
1 200
+0.2%
|
41,77
|
50 123 USD
|
|
|
2018-07-20 |
2018-07-19 |
A
Achat
|
Small Derek A
CEO and President
Administrateur exécutif
|
1 200
+0.2%
41,19
49 428 USD
|
1 200
+0.2%
|
41,19
|
49 428 USD
|
|
|
2018-07-03 |
2018-07-02 |
VP
Vente planifiée
|
RINGO WILLIAM R
Administrateur non-exécutif
|
1 000
-4.9%
38,50
38 503 USD
|
1 000
-4.9%
|
38,50
|
38 503 USD
|
|
|
2018-06-01 |
2018-06-01 |
VP
Vente planifiée
|
RINGO WILLIAM R
|
1 000
-4.9%
42,47
42 470 USD
|
1 000
-4.9%
|
42,47
|
42 470 USD
|
|
|
2018-05-02 |
2018-05-01 |
VP
Vente planifiée
|
RINGO WILLIAM R
Administrateur non-exécutif
|
1 000
-4.9%
43,06
43 060 USD
|
1 000
-4.9%
|
43,06
|
43 060 USD
|
|
|
2018-04-02 |
2018-04-02 |
VP
Vente planifiée
|
RINGO WILLIAM R
|
1 000
-4.9%
49,32
49 320 USD
|
1 000
-4.9%
|
49,32
|
49 320 USD
|
|
|
2018-03-02 |
2018-03-01 |
VP
Vente planifiée
|
RINGO WILLIAM R
|
1 000
-4.9%
56,37
56 370 USD
|
1 000
-4.9%
|
56,37
|
56 370 USD
|
|
|
2018-02-02 |
2018-02-01 |
VP
Vente planifiée
|
RINGO WILLIAM R
Administrateur non-exécutif
|
1 000
-4.9%
46,86
46 860 USD
|
1 000
-4.9%
|
46,86
|
46 860 USD
|
|
|
2018-01-03 |
2018-01-02 |
VP
Vente planifiée
|
RINGO WILLIAM R
Administrateur non-exécutif
|
1 000
-4.9%
45,04
45 040 USD
|
1 000
-4.9%
|
45,04
|
45 040 USD
|
|
|
2017-12-04 |
2017-12-01 |
VP
Vente planifiée
|
RINGO WILLIAM R
|
1 000
-4.9%
49,37
49 370 USD
|
1 000
-4.9%
|
49,37
|
49 370 USD
|
|
|
2017-11-03 |
2017-11-01 |
VP
Vente planifiée
|
RINGO WILLIAM R
|
1 000
-4.9%
29,55
29 550 USD
|
1 000
-4.9%
|
29,55
|
29 550 USD
|
|
|
2017-10-17 |
2017-10-16 |
VP
Vente planifiée
|
RINGO WILLIAM R
|
1 000
-4.9%
33,70
33 700 USD
|
1 000
-4.9%
|
33,70
|
33 700 USD
|
|
|
2017-05-16 |
2017-05-12 |
V
Vente
|
RINGO WILLIAM R
Administrateur non-exécutif
|
3 461
-100.0%
22,00
76 142 USD
|
3 461
-100.0%
|
22,00
|
76 142 USD
|
|
|
2016-02-12 |
2016-02-11 |
A
Achat
|
Small Derek A
CEO and President
Administrateur exécutif
|
1 555
+0.2%
5,56
8 647 USD
|
1 555
+0.2%
|
5,56
|
8 647 USD
|
|
|
2016-02-12 |
2016-02-10 |
A
Achat
|
Small Derek A
CEO and President
Administrateur exécutif
|
8 445
+1.4%
5,52
46 633 USD
|
8 445
+1.4%
|
5,52
|
46 633 USD
|
|
